All Stories

  1. Diagnostic accuracy of an identification tool for localized neuropathic pain based on the IASP criteria
  2. Modeling the Predictive Value of Pain Intensity on Costs and Resources Utilization in Patients With Peripheral Neuropathic Pain
  3. Prevalence of pain and relative diagnostic performance of screening tools for neuropathic pain in cancer patients: A cross‐sectional study
  4. Pain in the cancer patient: different pain characteristics CHANGE pharmacological treatment requirements
  5. Managing chronic pain in elderly patients requires a CHANGE of approach
  6. Pharmacoeconomic Outcomes for Pregabalin: A Systematic Review in Neuropathic Pain, Generalized Anxiety Disorder, and Epilepsy from a Spanish Perspective
  7. Clinical and Resource Utilization Patterns in Patients with Refractory Neuropathic Pain Prescribed Pregabalin for the First Time in Routine Medical Practice in Primary Care Settings in Spain
  8. Chronic pain patients need a multidisciplinary approach
  9. Cost Savings Associated With Early Initiation of Pregabalin in the Management of Peripheral Neuropathic Pain
  10. Survey of European patients assessing their own noncancer chronic pain: results from Spain
  11. What is Sciatica and Radicular Pain?
  12. How are Sciatica and Spinal Radicular Pain Classified?
  13. What are the Causes of Sciatica and Radicular Pain?
  14. High prevalence of confirmed, but also of potential and believed, neuropathic pain in pain clinics
  15. Pain Alleviation and Patient-Reported Health Outcomes following Switching to Pregabalin in Individuals with Gabapentin-Refractory Neuropathic Pain in Routine Medical Practice
  16. A Cost-Effectiveness Analysis of the Effect of Pregabalin Versus Usual Care in the Treatment of Refractory Neuropathic Pain in Routine Medical Practice in Spain
  17. The chronic pain conundrum: should we CHANGE from relying on past history to assessing prognostic factors?
  18. Is morphine still the best reference opioid?
  19. Costs and Health Resources Utilization Following Switching to Pregabalin in Individuals with Gabapentin-Refractory Neuropathic Pain: A post hoc Analysis
  20. S509 EPIDEMIOLOGICAL STUDY FOR THE DETERMINATION OF NEUROPATHIC PAIN PREVALENCE IN SPANISH PAIN UNITS
  21. T270 EFFECT OF PREGABALIN ON COST AND CLINICAL CONSEQUENCES IN GABAPENTIN-REFRACTORY PATIENTS WITH PERIPHERAL NEUROPATHIC PAIN IN PRIMARY CARE SETTINGS
  22. F519 EFFECT OF PREGABALIN ON PATIENT-REPORTED OUTCOMES IN GABAPENTIN-REFRACTORY PATIENTS WITH NEUROPATHIC PAIN: FINDINGS FROM A NON-INTERVENTIONAL TRIAL IN REAL-WORLD SETTINGS
  23. S623 EFFECT OF PREGABALIN ON REDUCTION OF CONCOMITANT PHARMACOLOGICAL AND NON-PHARMACOLOGICAL ANALGESIC TREATMENTS USE IN GABAPENTIN-REFRACTORY PATIENTS WITH PERIPHERAL NEUROPATHIC PAIN
  24. A Cost-Consequences analysis of the effect of Pregabalin in the treatment of peripheral Neuropathic Pain in routine medical practice in Primary Care settings
  25. Pain, health related quality of life and healthcare resource utilization in Spain
  26. The association of pain with labor force participation, absenteeism, and presenteeism in Spain
  27. Pregabalin and gabapentin in matched patients with peripheral neuropathic pain in routine medical practice in a primary care setting: Findings from a cost-consequences analysis in a nested case-control study
  28. Patient-reported Outcomes in Subjects with Neuropathic Pain Receiving Pregabalin: Evidence from Medical Practice in Primary Care Settings
  29. 900 TREATMENT OF LUMBOSACRAL RADICULOPATHY PAIN WITH BIPOLAR PULSED RADIOFREQUENCY. PRELIMINARY RESULTS
  30. Prevalence and Characterization of Neuropathic Pain in a Primary-Care Setting in Spain
  31. Trigeminal Neuralgia Treated With Pregabalin in Family Medicine Settings: Its Effect on Pain Alleviation and Cost Reduction
  32. Validity and reliability of the Spanish version of the DN4 (Douleur Neuropathique 4 questions) questionnaire for differential diagnosis of pain syndromes associated to a neuropathic or somatic component
  33. 932 VALIDITY OF THE LANSS SCALE FOR DIFFERENTIAL DIAGNOSIS OF PATIENTS WITH NEUROPATHIC OR MIXED PAIN VERSUS NON-NEUROPATHIC PAIN
  34. 931 LINGUISTIC VALIDATION INTO SPANISH OF THE LANSS (LEEDS ASSESSMENT OF NEUROPATHIC SYMPTOMS AND SIGNS) SCALE